Cinctive Capital Management LP Buys New Holdings in Chemed Corporation $CHE

Cinctive Capital Management LP purchased a new position in Chemed Corporation (NYSE:CHE) during the third quarter, HoldingsChannel reports. The fund purchased 1,478 shares of the company’s stock, valued at approximately $662,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Smartleaf Asset Management LLC grew its holdings in Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after buying an additional 25 shares in the last quarter. First Horizon Corp purchased a new position in shares of Chemed in the third quarter worth $31,000. Pilgrim Partners Asia Pte Ltd bought a new position in shares of Chemed during the third quarter worth $45,000. HM Payson & Co. boosted its position in shares of Chemed by 35.5% during the third quarter. HM Payson & Co. now owns 103 shares of the company’s stock worth $46,000 after acquiring an additional 27 shares during the last quarter. Finally, Geneos Wealth Management Inc. grew its stake in Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after acquiring an additional 76 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Insider Transactions at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $403.18, for a total value of $806,360.00. Following the completion of the sale, the chief executive officer directly owned 93,719 shares of the company’s stock, valued at $37,785,626.42. This trade represents a 2.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 3.29% of the stock is currently owned by company insiders.

Analyst Ratings Changes

CHE has been the topic of a number of research reports. Zacks Research downgraded shares of Chemed from a “hold” rating to a “strong sell” rating in a report on Wednesday, March 4th. Royal Bank Of Canada restated a “sector perform” rating and set a $422.00 price objective (down from $572.00) on shares of Chemed in a research report on Friday, February 27th. Oppenheimer reduced their target price on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Jefferies Financial Group downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Two research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $498.00.

Chemed Stock Down 0.7%

CHE stock opened at $398.87 on Tuesday. Chemed Corporation has a 52 week low of $385.00 and a 52 week high of $623.60. The firm has a market capitalization of $5.49 billion, a P/E ratio of 21.71, a price-to-earnings-growth ratio of 1.59 and a beta of 0.47. The company has a fifty day simple moving average of $440.69 and a two-hundred day simple moving average of $440.44.

Chemed (NYSE:CHE) last posted its earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share for the quarter, missing analysts’ consensus estimates of $7.02 by ($0.60). The business had revenue of $639.34 million during the quarter, compared to the consensus estimate of $659.09 million. Chemed had a return on equity of 25.66% and a net margin of 10.48%.The business’s quarterly revenue was down .1% on a year-over-year basis. During the same quarter last year, the firm earned $6.83 earnings per share. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. As a group, analysts anticipate that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Monday, February 23rd were paid a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Monday, February 23rd. Chemed’s payout ratio is presently 13.06%.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.